diabetes. Diabetes mellitus due to underlying condition with diabetic neuropathy, unspecified
Conditions
Sponsors
Rafsanjan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
40 Years to No maximum
Inclusion criteria
Inclusion criteria: Having type II diabetes Age over 40 years old Inform consent for participate in the study History of diabetes for at least five years
Exclusion criteria
Exclusion criteria: Participate in another research project Having other physical illnesses in addition to diabetes Pregnancy and lactation Allergy to medicinal plants
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mean blood inflammatory factors. Timepoint: At the beginning of the study (before the intervention) and 12 weeks after the intervention. Method of measurement: Biochemical autoanalyzer. | — |
Secondary
| Measure | Time frame |
|---|---|
| Liver enzymes. Timepoint: At the beginning of the study (before the intervention) and 12 weeks after the intervention. Method of measurement: Biochemical autoanalyzer.;Michigan neuropathy questionnaire. Timepoint: At the beginning of the study (before the intervention) and 12 weeks after the intervention. Method of measurement: questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactVahid mohammadi shahrokhi
Rafsanjan University of Medical Sciences
Outcome results
None listed